Ammara Mushtaq: How Research Fills the Gaps in Fast Paced Healthcare
Ammara Mushtaq, Principal Investigator Principal Investigator at Rasai Research, shared a post on LinkedIn.
“In clinical research, regulations go to great lengths to ensure that participants clearly understand they may or may not benefit from a study, and that there may be unknown risks.
We make this very clear to every participant during the consent process.
However, within those regulatory boundaries, there is something I often reflect on.
Sometimes, participants may benefit simply from the screening process itself.
Just this month alone, while screening participants for research studies:
I worked with one participant to optimize their diabetes and improve HbA1c control so they could qualify for a study.
I spoke with another participant about the importance of anticoagulation for their atrial fibrillation, which was indicated but had not yet been addressed.
In both cases, these were conditions that needed attention regardless of the study.
But the reality is, in a fast-paced, RVU-driven healthcare environment, these issues may not always get addressed in a 5-minute primary care visit.
Because they came in for a research screening visit, their conditions were reviewed, discussed, and ultimately optimized.
We remain compliant.
We never advertise research as a direct benefit to participants.
But facts are facts.
Clinical research helps improve and sometimes save lives in more ways than one.”

Stay updated with Hemostasis Today.
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’